Amitriptyline withdrawal symptoms

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Amitriptyline Withdrawal Symptoms: An Overview

Introduction to Amitriptyline Withdrawal

Amitriptyline, a tricyclic antidepressant (TCA), is widely used for treating depression and other conditions. However, abrupt cessation of amitriptyline can lead to withdrawal symptoms, which can be challenging for patients. This article synthesizes research findings on the withdrawal symptoms associated with amitriptyline.

Common Withdrawal Symptoms

Exacerbation of Original Symptoms

One of the primary withdrawal symptoms is the exacerbation of the original symptoms for which amitriptyline was prescribed. Patients often experience a resurgence of depressive symptoms, including psychomotor retardation and sleep disturbances, within weeks of discontinuation 123.

Neurological and Cholinergic Symptoms

Withdrawal from amitriptyline can also present with neurological signs that mimic acute toxicity. Symptoms such as irritability, dream disturbances, restlessness, and signs of cholinergic hyperactivity (e.g., sweating, nausea) are common during the initial weeks of withdrawal 13.

Movement Disorders

Amitriptyline withdrawal has been associated with various movement disorders, including myoclonus, dyskinesia, dystonia, and akathisia. These symptoms typically resolve within a month after discontinuation of the drug .

Impact of Withdrawal on Depression Recurrence

Recurrence of Depression

Studies have shown that discontinuing long-term amitriptyline treatment can lead to a recurrence of depression in a significant number of patients. In one study, 8 out of 10 patients who had their medication tapered and discontinued became depressed again within 3 to 15 weeks . This highlights the importance of careful management during the withdrawal process.

Role of Psychotherapy

Interestingly, the addition of psychotherapy during the withdrawal phase did not significantly impact the recurrence of depressive symptoms. Maintenance on amitriptyline was more effective in preventing symptom recrudescence compared to early withdrawal, regardless of whether psychotherapy was provided .

Managing Withdrawal Symptoms

Gradual Tapering

Gradual tapering of amitriptyline is recommended to minimize withdrawal symptoms. Abrupt cessation can lead to severe withdrawal phenomena, making it difficult to distinguish from acute toxicity 13.

Supportive Measures

Supportive measures, including regular follow-up and symptomatic treatment, can help manage withdrawal symptoms. For instance, in a study involving migraineurs, patients were supported with explanations of their condition and regular follow-ups, which helped in reducing analgesic intake and managing headache symptoms .

Conclusion

Amitriptyline withdrawal can lead to a range of symptoms, including the exacerbation of original depressive symptoms, neurological and cholinergic signs, and movement disorders. Gradual tapering and supportive measures are crucial in managing these symptoms effectively. Understanding these withdrawal phenomena is essential for healthcare providers to ensure safe and effective discontinuation of amitriptyline.

Sources and full results

Most relevant research papers on this topic

Acute Amitriptyline Withdrawal and Hyponatraemia

Amitriptyline withdrawal can cause symptoms similar to acute toxicity, with hyponatraemia potentially exacerbating the patient's condition.

Case Report

1993·

2citations

·P. Davison et al.

Drug Safety·

DOI

Effects of maintenance amitriptyline and psychotherapy on symptoms of depression

Maintenance amitriptyline effectively prevents symptom recrudescence, while psychotherapy shows no significant advantage over low contact on symptoms.

RCTHighly Cited

1975·

131citations

·E. Paykel et al.

Psychological Medicine·

DOI

Recurrence of depression after discontinuation of long-term amitriptyline treatment.

Discontinuing long-term amitriptyline treatment can lead to depression and psychomotor retardation in some patients, but longstanding side effects are relieved.

Non-RCT

1982·

58citations

·D. Bialos et al.

The American journal of psychiatry·

DOI

The Link Between Amitriptyline and Movement Disorders: Clinical Profile and Outcome.

Amitriptyline use is associated with various movement disorders, particularly myoclonus, dystonia, and dyskinesias, with stutters and restless legs syndrome being less common associations.

Systematic Review

2020·

10citations

·J. Rissardo et al.

Annals of the Academy of Medicine, Singapore·

DOI

Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.

Abrupt outpatient withdrawal of analgesics in migraineurs can effectively reduce chronic headaches and improve analgesic intake, with 37 patients experiencing relief by 6 months.

Case ReportHighly Cited

1991·

108citations

·R. Hering et al.

Lancet·

DOI

Org 3770 versus amitriptyline: A 6‐week randomized double‐blind multicentre trial in hospitalized depressed patients

Org 3770 has similar antidepressant efficacy to amitriptyline with a more favourable tolerability profile in patients with major depression.

RCT

1995·

60citations

·M. Zivkov et al.

Human Psychopharmacology: Clinical and Experimental·

DOI

Amitriptyline in childhood enuresis

Amitriptyline effectively reduces nighttime enuresis in children aged 12 and over, with minimal adverse effects.

RCT

1966·

17citations

·A. Poussaint et al.

Clinical Pharmacology & Therapeutics·

DOI

Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.

Paroxetine shows an antidepressant effect similar to amitriptyline with a different side-effect profile, both decreasing REM sleep, and both have an alerting effect on sleep without negatively impacting subjective sleep quality.

RCTHighly Cited

1995·

94citations

·L. Staner et al.

Sleep·

DOI

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

L-tryptophan, amitriptyline, and L-tryptophan-amitriptyline combination are more effective than placebo in treating depression in general practice.

RCTHighly Cited

1982·

184citations

·J. Thomson et al.

Psychological Medicine·

DOI

Long-term amitriptyline in chronic depression.

Most patients on long-term antidepressants experience a recurrence of depressive symptoms when medication is discontinued.

RCT

1985·

14citations

·E. Giller et al.

The Hillside journal of clinical psychiatry

Try another search

levothyroxine pictures

list medication for depression

metabolite thc

sucralose in protein powder

red ginsing

5mg of oxy